Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

. 2016 Jul ; 101 (7) : e299-302. [epub] 20160421

Jazyk angličtina Země Itálie Médium print-electronic

Typ dokumentu dopisy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid27102498

Grantová podpora
C34999/A18087 Cancer Research UK - United Kingdom

E-zdroje Online Plný text
Odkazy

PubMed 27102498
PubMed Central PMC5004477
DOI 10.3324/haematol.2015.140202
PII: haematol.2015.140202
Knihovny.cz E-zdroje

Zobrazit více v PubMed

Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000; 343(26):1910–1916. PubMed

Ibbotson R, Athanasiadou A, Sutton LA, et al. Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant. Leukemia. 2012; 26(1):170–172. PubMed

Schwaenen C, Nessling M, Wessendorf S, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA. 2004;101(4):1039–1044. PubMed PMC

Sellmann L, Gesk S, Walter C, et al. Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia. Br J Haematol. 2007;138(2):217–220. PubMed

Gunnarsson R, Mansouri L, Isaksson A, et al. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica. 2011;96(8):1161–1169. PubMed PMC

Del Giudice I, Rossi D, Chiaretti S, et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica. 2012;97(3):437–441. PubMed PMC

Baliakas P, Hadzidimitriou A, Sutton LA, et al. Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia. 2015; 29(2):329–336. PubMed

Vardi A, Agathangelidis A, Sutton LA, et al. IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications. Clin Cancer Res. 2014;20(2):323–330. PubMed

Belessi C, Stamatopoulos K, Hadzidimitriou A, et al. Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia. Mol Med. 2005;11(1–12):52–58. PubMed PMC

Hadzidimitriou A, Darzentas N, Murray F, et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood. 2009; 113(2):403–411. PubMed

Xu W, Wang YH, Fan L, et al. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia. Leuk Res. 2011;35(8):1060–1065. PubMed

Dearden C. Disease-specific complications of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2008;450–456. PubMed

Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma. 2005;46(1):49–54. PubMed

Baliakas P, Iskas M, Gardiner A, et al. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data. Am J Hematol. 2014; 89(3):249–255. PubMed

Villamor N, Conde L, Martinez-Trillos A, et al. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia. 2013;27(5):1100–1106. PubMed

Najít záznam

Citační ukazatele

Možnosti archivace